increas
influenza
variant
detect
us
recent
year
septemb
ontario
resid
diagnos
influenza
variant
infect
demonstr
cross
reactiv
gene
cdc
realtim
pcr
suggest
laboratori
use
gene
pcr
confirm
subtyp
would
incorrectli
report
variant
subtyp
unless
molecular
investig
elsevi
bv
right
reserv
increas
influenza
variant
detect
us
recent
year
influenza
virus
normal
circul
swine
call
variant
virus
found
peopl
decemb
septemb
influenza
variant
v
v
v
case
identifi
septemb
year
old
male
ontario
resid
diagnos
influenza
infect
first
detect
variant
influenza
strain
individu
canada
case
unknown
influenza
immun
histori
recent
travel
within
canada
time
close
contact
swine
unit
state
close
contact
cattl
attend
swine
fair
could
ascertain
begin
septemb
becam
ill
gastrointestin
symptom
unknown
etiolog
follow
acut
respiratori
symptom
septemb
admit
local
area
hospit
pneumonia
follow
admiss
discharg
hospit
readmit
septemb
worsen
respiratori
symptom
subsequ
transfer
tertiari
care
center
requir
admiss
intens
care
unit
case
two
separ
treatment
cours
oseltamivir
administ
first
cours
five
day
mg
twice
daili
start
septemb
second
sevenday
cours
mg
twice
daili
start
septemb
time
write
case
discharg
home
follow
extend
stay
intens
care
howev
addit
travel
exposur
inform
unattain
one
close
contact
case
report
symptom
influenzalik
ill
ili
person
test
neg
influenza
phol
perform
larg
proport
primari
respiratori
viral
test
provinc
ontario
varieti
clinic
set
includ
ambulatori
hospit
outbreak
specimen
hospit
outbreak
patient
test
influenza
matrix
gene
influenza
b
gene
use
cdc
protocol
influenza
aposit
subtyp
season
influenza
ha
gene
cdc
assay
influenza
na
gene
inhous
assay
perform
follow
emerg
infect
us
phol
implement
screen
select
influenza
aposit
specimen
swine
np
gene
pcr
screen
sampl
influenzaa
posit
neg
initi
subtyp
assay
design
unsubtyp
investig
includ
season
swine
np
avian
rrtpcr
subtyp
target
use
cdc
protocol
addit
endpoint
swine
influenza
matrix
gene
pcr
develop
canada
nation
microbiolog
laboratori
nml
influenzaneg
outbreak
icu
sampl
also
test
use
nasopharyng
swab
case
collect
septemb
test
posit
influenza
viral
cultur
specimen
collect
septemb
bronchoalveolar
lavag
also
posit
influenza
mrvp
assay
subsequ
nasopharyng
swab
collect
septemb
test
neg
influenza
septemb
sampl
initi
unsubtyp
influenza
subtyp
assay
routin
use
phol
influenza
na
gene
season
gene
realtim
subtyp
pcr
season
season
season
neg
realtim
pcr
swine
nucleoprotein
np
gene
gene
posit
pcr
swine
gene
result
suggest
influenza
viru
swine
origin
subtyp
whole
genom
sequenc
commenc
phol
sequenc
data
share
nation
microbiolog
laboratori
nml
canada
refer
laboratori
nml
receiv
primari
sampl
cultur
materi
investig
nml
test
perform
cultur
materi
neg
season
pandem
na
variant
v
antivir
suscept
test
show
isol
resist
amantadin
sensit
oseltamivir
zanamivir
complet
sequenc
analysi
pa
ha
na
gene
viral
rna
extract
first
passag
rhesu
monkey
kidney
cell
reveal
sequenc
similar
virus
found
us
swine
tabl
even
lower
nucleotid
homolog
like
viru
na
gene
consist
viru
detect
phol
inhous
na
gene
realtim
pcr
due
sever
scatter
mismatch
primer
probe
bind
site
comparison
antigen
isol
examin
use
ferret
antisera
hi
assay
crossreact
hi
titer
refer
hi
titer
serolog
profil
suggest
close
antigen
homolog
strain
report
base
test
result
phol
nml
conclud
patient
infect
influenza
v
viru
tabl
molecular
character
need
repres
select
influenza
virus
molecular
investig
sequenc
would
ultim
detect
signific
circul
variant
infrastructur
also
enabl
rapid
detect
virul
influenza
virus
highli
pathogen
avian
influenza
also
suggest
repres
sampl
influenza
virus
varieti
set
eg
critic
care
outbreakrel
communitybas
screen
molecular
method
order
detect
variant
follow
emerg
infect
us
phol
screen
select
influenza
subtyp
specimen
swine
np
gene
pcr
screen
howev
np
gene
pcr
posit
influenza
well
swine
origin
gener
exposur
travelrel
inform
poorli
complet
laboratori
requisit
consist
ask
patient
present
influenzalik
ill
particularli
influenza
season
henc
mani
variant
case
would
miss
anticip
find
variant
viru
would
rare
thu
essenti
test
patient
ha
na
gene
influenza
howev
systemat
sequenc
primarili
conduct
order
detect
chang
influenza
genom
could
impact
vaccin
effect
could
optim
detect
variant
work
conduct
refer
laboratori
part
influenza
surveil
extern
sourc
fund
studi
jonathan
b
gubbay
receiv
research
grant
glaxosmithklin
inc
work
resist
neuraminidas
inhibitor
june
public
health
ontario
receiv
research
grant
glaxosmithklin
studi
phenotyp
resist
influenza
viru
research
ethic
approv
requir
